Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Fruquintinib; Drug: Sintilimab; Drug: Inulin Sponsors: Wuhan Union Hospital, China; Huazhong University of Science and Technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | China Health | Colorectal Cancer | COVID-19 | Hospitals | Oral Cancer | Research | Science